- Trials with a EudraCT protocol (144)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
144 result(s) found for: ST depression.
Displaying page 1 of 8.
EudraCT Number: 2006-006089-40 | Sponsor Protocol Number: 2006TUDOR_01 | Start Date*: 2007-03-20 | |||||||||||
Sponsor Name:University Hospitals Bristol NHS Foundation Trust | |||||||||||||
Full Title: High dose corticosteroid pulses in treatment-resistant depression : a randomized double-blind placebo-controlled pilot study | |||||||||||||
Medical condition: Resistant depression | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-007290-20 | Sponsor Protocol Number: TMC-BIV-08-03 | Start Date*: Information not available in EudraCT | ||||||||||||||||
Sponsor Name:The Medicines Company UK Ltd. | ||||||||||||||||||
Full Title: European Ambulance Acute Coronary Syndrome Angiox Trial: EUROMAX | ||||||||||||||||||
Medical condition: Patients presenting with ST-Segment Elevation Acute Coronary Syndrome (STE-ACS) planned for a primary Percutaneous Coronary Intervention (PCI) management strategy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) AT (Completed) DK (Completed) FR (Completed) NL (Completed) CZ (Completed) ES (Completed) PL (Completed) IT (Completed) SI (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-003504-22 | Sponsor Protocol Number: UCDCRC/015/006 | Start Date*: 2015-10-09 | |||||||||||
Sponsor Name:UCD | |||||||||||||
Full Title: The NAPRESSIM trial. The use of low dose prophylactic naloxone infusion to prevent respiratory depression with intrathecal morphine. | |||||||||||||
Medical condition: Respiratory Depression | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004238-25 | Sponsor Protocol Number: 2012-004-0402-CARD | Start Date*: 2015-02-09 | |||||||||||||||||||||
Sponsor Name:The Royal Wolverhampton NHS Trust | |||||||||||||||||||||||
Full Title: Pharmacokinetics and Pharmacodynamics of Platelet P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention (PCI) for Acute Myocardial Infarction: A Pilot Study | |||||||||||||||||||||||
Medical condition: ST-segment elevation myocardial infarction Non ST-segment elevation myocardial infarction | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-001544-23 | Sponsor Protocol Number: Ze 117 | Start Date*: 2007-09-04 | |||||||||||
Sponsor Name:Max Zeller Söhne AG | |||||||||||||
Full Title: Hypericum-Extrakt Ze 117 (Zeller AG): Klinische Studie zur Verminderung von Rückfällen bei Patienten mit Depression nach DSM-IV (Mittelschwere Major Depression: einzeln/rezi- divierend) | |||||||||||||
Medical condition: Patients with Major Depression DSM IV middle serious | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004764-18 | Sponsor Protocol Number: 01-17 | Start Date*: 2017-07-24 |
Sponsor Name:St Patrick’s Mental Health Services | ||
Full Title: Ketamine as an adjunctive therapy for Major Depression - a randomised controlled pilot trial: The KARMA-Dep Trial | ||
Medical condition: Depression | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-004210-26 | Sponsor Protocol Number: 14/0647 | Start Date*: 2016-11-22 | |||||||||||
Sponsor Name:PRIMENT Clinical Trials Unit, UCL | |||||||||||||
Full Title: A Phase IV double blind multi-site, individually randomised parallel group controlled trial investigating the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in pati... | |||||||||||||
Medical condition: Depression | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023779-24 | Sponsor Protocol Number: M10-1028 | Start Date*: 2010-12-06 |
Sponsor Name:Stichting Toegepast Caridologisch Onderzoek | ||
Full Title: A Comparison of Drug Eluting and Bare Metal Stents with Bivalirudin during PCI or Bivalirudin for 4 hours in Acute Coronary Syndromes. The Eindhoven Reperfusion Study | ||
Medical condition: Patients with ACS who are scheduled for primary PCI (STEMI) or for immediate PCI < 2.5 hours or early PCI < 48 hours (NSTEMI) and who are pre-treated with HLD clopidogrel | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004004-20 | Sponsor Protocol Number: UI04/6748 | Start Date*: 2005-09-26 |
Sponsor Name:University of Leeds | ||
Full Title: A Randomised, Double-blind, Placebo Controlled trial to test the efficacy of St John's Wort (Hypericum Perforatum) for Premenstrual Syndrome. | ||
Medical condition: The 'premenstrual syndrome' is a cyclical condition occurring 7-10 days before the onset of menstruation, and is relieved at, or shortly after commencement of menstrual flow. The most commonly repo... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-000425-22 | Sponsor Protocol Number: 68-4986/12484 | Start Date*: 2007-12-19 | |||||||||||
Sponsor Name:Bayer Healthcare AG | |||||||||||||
Full Title: Phase IIa Efficacy and Safety Trial of capadenoson in Patients with Chronic Stable Angina | |||||||||||||
Medical condition: Patients with Chronic Stable Angina | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002116-32 | Sponsor Protocol Number: MTM-04 | Start Date*: 2015-09-23 | ||||||||||||||||||||||||||
Sponsor Name:Køge Hospital | ||||||||||||||||||||||||||||
Full Title: The effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep disturbances in patients after acute myocardial syndrome | ||||||||||||||||||||||||||||
Medical condition: Depression Anxiety Sleep disturbances Circadian disturbances | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-003421-28 | Sponsor Protocol Number: 11-18 | Start Date*: 2019-01-16 |
Sponsor Name:St Patrick's Mental Health Services | ||
Full Title: Ketamine interleaved with electroconvulsive therapy for depression, a pragmatic randomised controlled pilot trial (KITE-Dep) | ||
Medical condition: Depression | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-001417-26 | Sponsor Protocol Number: STW/K/01707 | Start Date*: 2009-01-22 |
Sponsor Name:Steigerwald Arzneimittelwerk GmbH | ||
Full Title: Double blind, randomized, placebo-controlled, mulitcentric clinical trial to evaluate the relapse prevention of a hypericum extract in outdoor patients with moderate depressive episodes (major depr... | ||
Medical condition: Moderate depressive episodes | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002020-37 | Sponsor Protocol Number: 20/15 | Start Date*: 2015-09-03 | |||||||||||
Sponsor Name:St Patrick's Mental Health Services | |||||||||||||
Full Title: Ketamine for relapse prevention in recurrent depressive disorder: a randomised, controlled pilot trial | |||||||||||||
Medical condition: Recurrent depressive disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000313-38 | Sponsor Protocol Number: EFC5965 | Start Date*: 2007-01-24 | |||||||||||
Sponsor Name:Sanofi-aventis Recherche & Développement | |||||||||||||
Full Title: Randomized, multinational, double-blind study, comparing a high loading dose regimen of clopidogrel versus standard dose in patients with unstable angina or myocardial infarction managed with an ea... | |||||||||||||
Medical condition: Patients with non-ST segment elevation myocardial infarction managed with an early PCI. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Completed) FI (Completed) IE (Completed) SK (Completed) FR (Completed) SE (Completed) DE (Completed) AT (Completed) EE (Completed) BG (Completed) GR (Completed) IT (Completed) GB (Completed) LT (Completed) NL (Completed) LV (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002293-54 | Sponsor Protocol Number: Apex01version6 | Start Date*: 2007-11-29 |
Sponsor Name:University of Dundee | ||
Full Title: The APEX Trial: Effects of Allopurinol on Coronary and Peripheral Endothelial Function in Patients with Cardiac Syndrome X | ||
Medical condition: Patients with cardiac syndrome X (typical anginal-like chest pain and normal coronary arteriograms) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-001022-17 | Sponsor Protocol Number: 170304 | Start Date*: 2017-05-08 |
Sponsor Name:Breastcentre, Capio St Gorans Hospital | ||
Full Title: Vitamin D supplementation to breast cancer patients with adjuvant endocrine treatment – An observational clinical study where the patient is its own control. | ||
Medical condition: Breast cancer survivors on adjuvant treatment with an aromatase inhibitor having joint pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002232-16 | Sponsor Protocol Number: TAK-653-2001 | Start Date*: 2017-12-15 | |||||||||||
Sponsor Name:Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company, Ltd | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-653 in the Treatment of Subjects with Treatment-Resistant Depression | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-013956-62 | Sponsor Protocol Number: DEMIJO | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:University Medical Center of the University Ulm | |||||||||||||
Full Title: Preparation of Neuroplant® 300mg N in film-coated tablets (St. John´s wort, SJW) in the treatment of mild to moderate Major Depressive Disorder (MDD) in adolescents from 12 to 17 years (inclusive):... | |||||||||||||
Medical condition: Mild to moderate MDD acc. DSM-IV-TR in adolescents (12−17years inclusive) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002708-25 | Sponsor Protocol Number: RIVAROXACS3001 (BAY59-7939/13194) | Start Date*: 2008-11-27 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Event-Driven Multicenter Study to Evaluate the Efficacy and Safety of Rivaroxaban in Subjects with a Recent Acute Coronary Syndrome The ATLAS ACS 2 ... | |||||||||||||
Medical condition: Acute Coronary Syndrome (ACS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) LT (Completed) DE (Completed) PT (Completed) SK (Completed) HU (Completed) FR (Completed) DK (Completed) GB (Completed) NL (Completed) ES (Completed) IT (Completed) LV (Completed) CZ (Completed) BG (Completed) BE (Prematurely Ended) GR (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
